{"id":3710,"date":"2025-01-22T06:00:09","date_gmt":"2025-01-22T05:00:09","guid":{"rendered":"https:\/\/rvh-synergie.org\/actualites\/les-tests-de-classification-genomique-jouent-un-role-heterogene-dans-la-classification-du-risque-de-cancer-de-la-prostate\/"},"modified":"2025-01-22T06:00:10","modified_gmt":"2025-01-22T05:00:10","slug":"les-tests-de-classification-genomique-jouent-un-role-heterogene-dans-la-classification-du-risque-de-cancer-de-la-prostate","status":"publish","type":"post","link":"https:\/\/rvh-synergie.org\/actualites\/les-tests-de-classification-genomique-jouent-un-role-heterogene-dans-la-classification-du-risque-de-cancer-de-la-prostate\/","title":{"rendered":"Les tests de classification g\u00e9nomique jouent un r\u00f4le h\u00e9t\u00e9rog\u00e8ne dans la classification du risque de cancer de la prostate"},"content":{"rendered":"<div>\n<div class=\"article-gallery lightGallery\">\n<div data-thumb=\"https:\/\/scx1.b-cdn.net\/csz\/news\/tmb\/2025\/genomic-classifier-tes.jpg\" data-src=\"https:\/\/scx2.b-cdn.net\/gfx\/news\/2025\/genomic-classifier-tes.jpg\" data-sub-html=\"\">\n<figure class=\"article-img\">\n<\/figure><\/div>\n<\/div>\n<p>Pour les patients atteints d&rsquo;un cancer de la prostate localis\u00e9 (CaP), les classificateurs g\u00e9nomiques (GC) bas\u00e9s sur les tissus n&rsquo;influencent pas syst\u00e9matiquement la classification des risques ou les d\u00e9cisions de traitement, selon une revue publi\u00e9e dans le <i>Annales de m\u00e9decine interne<\/i>.<\/p>\n<p>Amir Alishahi Tabriz, MD, Ph.D., MPH, du Moffitt Cancer Center \u00e0 Tampa, en Floride, et ses coll\u00e8gues ont men\u00e9 une revue syst\u00e9matique pour r\u00e9sumer l&rsquo;impact du Decipher, du Oncotype DX Genomic Prostate Score (GPS) et des GC Prolaris sur stratification du risque et d\u00e9cisions patient-clinicien concernant le choix du traitement chez les patients atteints d&rsquo;ACP localis\u00e9e envisageant un traitement de premi\u00e8re intention. Les \u00e9tudes sur la classification des risques et le choix du traitement apr\u00e8s les tests GC ont \u00e9t\u00e9 identifi\u00e9es ind\u00e9pendamment par deux enqu\u00eateurs.<\/p>\n<p>Les chercheurs ont identifi\u00e9 10 \u00e9tudes faisant \u00e9tat d\u2019une reclassification des risques apr\u00e8s des tests GC. Les patients \u00e0 tr\u00e8s faible risque ou \u00e0 faible risque atteints d&rsquo;ACP \u00e9taient plus susceptibles de voir leurs niveaux de risque class\u00e9s comme identiques ou inf\u00e9rieurs dans les \u00e9tudes observationnelles avec un faible risque de biais (GPS\u00a0: 100 \u00e0 88,1\u00a0%\u00a0; Decipher\u00a0: 87,2 \u00e0 82,9\u00a0%\u00a0; Prolaris : 76,9 %). Les tests GC avec GPS ont reclass\u00e9 respectivement 34,5 et 29,4\u00a0% des patients \u00e0 tr\u00e8s faible risque et \u00e0 faible risque dans une cat\u00e9gorie \u00e0 risque plus \u00e9lev\u00e9 dans une \u00e9tude randomis\u00e9e.<\/p>\n<p>Les d\u00e9cisions de traitement apr\u00e8s les tests GC sont rest\u00e9es inchang\u00e9es ou ont l\u00e9g\u00e8rement favoris\u00e9 une surveillance active sur la base de 12 \u00e9tudes observationnelles. Cependant, dans les analyses d\u2019un seul essai randomis\u00e9, moins de choix en mati\u00e8re de surveillance active apr\u00e8s les tests GPS ont \u00e9t\u00e9 observ\u00e9s.<\/p>\n<p>\u00ab Bien que les tests GC n&rsquo;influencent pas syst\u00e9matiquement la classification des risques ou les d\u00e9cisions de traitement, les diff\u00e9rences observ\u00e9es entre les \u00e9tudes observationnelles et randomis\u00e9es mettent en \u00e9vidence la n\u00e9cessit\u00e9 d&rsquo;essais bien con\u00e7us pour explorer le r\u00f4le des tests GC chez les patients atteints d&rsquo;ACP nouvellement diagnostiqu\u00e9e et envisageant un traitement de premi\u00e8re intention. \u00bb \u00e9crivent les auteurs.<\/p>\n<p>                                        <!-- print only --><\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Pour les patients atteints d&rsquo;un cancer de la prostate localis\u00e9 (CaP), les classificateurs g\u00e9nomiques (GC)<\/p>\n","protected":false},"author":1,"featured_media":3711,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[86],"tags":[391,3631,44,1331,3632,2425,49,1358,40,2411,72],"class_list":["post-3710","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-les-maladies","tag-cancer","tag-classification","tag-dans","tag-genomique","tag-heterogene","tag-jouent","tag-les","tag-prostate","tag-risque","tag-role","tag-tests","generate-columns","tablet-grid-50","mobile-grid-100","grid-parent","grid-50","resize-featured-image"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Les tests de classification g\u00e9nomique jouent un r\u00f4le h\u00e9t\u00e9rog\u00e8ne dans la classification du risque de cancer de la prostate - RVH-Synergie.org<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/rvh-synergie.org\/actualites\/les-tests-de-classification-genomique-jouent-un-role-heterogene-dans-la-classification-du-risque-de-cancer-de-la-prostate\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Les tests de classification g\u00e9nomique jouent un r\u00f4le h\u00e9t\u00e9rog\u00e8ne dans la classification du risque de cancer de la prostate - RVH-Synergie.org\" \/>\n<meta property=\"og:description\" content=\"Pour les patients atteints d&rsquo;un cancer de la prostate localis\u00e9 (CaP), les classificateurs g\u00e9nomiques (GC)\" \/>\n<meta property=\"og:url\" content=\"https:\/\/rvh-synergie.org\/actualites\/les-tests-de-classification-genomique-jouent-un-role-heterogene-dans-la-classification-du-risque-de-cancer-de-la-prostate\/\" \/>\n<meta property=\"og:site_name\" content=\"RVH-Synergie\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-22T05:00:09+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-22T05:00:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/01\/1737522009_Les-tests-de-classification-genomique-jouent-un-role-heterogene-dans.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Charles Martinez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Charles Martinez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/les-tests-de-classification-genomique-jouent-un-role-heterogene-dans-la-classification-du-risque-de-cancer-de-la-prostate\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/les-tests-de-classification-genomique-jouent-un-role-heterogene-dans-la-classification-du-risque-de-cancer-de-la-prostate\/\"},\"author\":{\"name\":\"Charles Martinez\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560\"},\"headline\":\"Les tests de classification g\u00e9nomique jouent un r\u00f4le h\u00e9t\u00e9rog\u00e8ne dans la classification du risque de cancer de la prostate\",\"datePublished\":\"2025-01-22T05:00:09+00:00\",\"dateModified\":\"2025-01-22T05:00:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/les-tests-de-classification-genomique-jouent-un-role-heterogene-dans-la-classification-du-risque-de-cancer-de-la-prostate\/\"},\"wordCount\":386,\"publisher\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#organization\"},\"image\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/les-tests-de-classification-genomique-jouent-un-role-heterogene-dans-la-classification-du-risque-de-cancer-de-la-prostate\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/01\/1737522009_Les-tests-de-classification-genomique-jouent-un-role-heterogene-dans.jpg\",\"keywords\":[\"cancer\",\"classification\",\"dans\",\"g\u00e9nomique\",\"h\u00e9t\u00e9rog\u00e8ne\",\"jouent\",\"Les\",\"prostate\",\"risque\",\"r\u00f4le\",\"tests\"],\"articleSection\":[\"Les maladies\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/les-tests-de-classification-genomique-jouent-un-role-heterogene-dans-la-classification-du-risque-de-cancer-de-la-prostate\/\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/les-tests-de-classification-genomique-jouent-un-role-heterogene-dans-la-classification-du-risque-de-cancer-de-la-prostate\/\",\"name\":\"Les tests de classification g\u00e9nomique jouent un r\u00f4le h\u00e9t\u00e9rog\u00e8ne dans la classification du risque de cancer de la prostate - RVH-Synergie.org\",\"isPartOf\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/les-tests-de-classification-genomique-jouent-un-role-heterogene-dans-la-classification-du-risque-de-cancer-de-la-prostate\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/les-tests-de-classification-genomique-jouent-un-role-heterogene-dans-la-classification-du-risque-de-cancer-de-la-prostate\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/01\/1737522009_Les-tests-de-classification-genomique-jouent-un-role-heterogene-dans.jpg\",\"datePublished\":\"2025-01-22T05:00:09+00:00\",\"dateModified\":\"2025-01-22T05:00:10+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/les-tests-de-classification-genomique-jouent-un-role-heterogene-dans-la-classification-du-risque-de-cancer-de-la-prostate\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/rvh-synergie.org\/actualites\/les-tests-de-classification-genomique-jouent-un-role-heterogene-dans-la-classification-du-risque-de-cancer-de-la-prostate\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/les-tests-de-classification-genomique-jouent-un-role-heterogene-dans-la-classification-du-risque-de-cancer-de-la-prostate\/#primaryimage\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/01\/1737522009_Les-tests-de-classification-genomique-jouent-un-role-heterogene-dans.jpg\",\"contentUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/01\/1737522009_Les-tests-de-classification-genomique-jouent-un-role-heterogene-dans.jpg\",\"width\":1280,\"height\":853,\"caption\":\"Les tests de classification g\u00e9nomique jouent un r\u00f4le h\u00e9t\u00e9rog\u00e8ne dans la classification du risque de cancer de la prostate\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/les-tests-de-classification-genomique-jouent-un-role-heterogene-dans-la-classification-du-risque-de-cancer-de-la-prostate\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/rvh-synergie.org\/actualites\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Les tests de classification g\u00e9nomique jouent un r\u00f4le h\u00e9t\u00e9rog\u00e8ne dans la classification du risque de cancer de la prostate\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#website\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/\",\"name\":\"RVH-Synergie.org\",\"description\":\"RVH-Synergie, site ind\u00e9pendant d&#039;informations sur la prise en charge des addictions.\",\"publisher\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/rvh-synergie.org\/actualites\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#organization\",\"name\":\"RVH-Synergie.org\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png\",\"contentUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png\",\"width\":512,\"height\":512,\"caption\":\"RVH-Synergie.org\"},\"image\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560\",\"name\":\"Charles Martinez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg\",\"contentUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg\",\"caption\":\"Charles Martinez\"},\"description\":\"Bonjour, je m'appelle Charles Martinez, r\u00e9dacteur passionn\u00e9 pour le m\u00e9dia RVH-synergie.org, d\u00e9di\u00e9 aux addictions et aux maladies. Depuis plus de dix ans, j'explore et rapporte les histoires poignantes des individus confront\u00e9s \u00e0 ces d\u00e9fis, tout en sensibilisant le public aux traitements novateurs et aux progr\u00e8s scientifiques dans ce domaine. Mon engagement r\u00e9side dans l'espoir de cr\u00e9er une communaut\u00e9 inform\u00e9e et empathique, pr\u00eate \u00e0 soutenir ceux qui luttent contre ces \u00e9preuves.\",\"sameAs\":[\"https:\/\/rvh-synergie.org\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Les tests de classification g\u00e9nomique jouent un r\u00f4le h\u00e9t\u00e9rog\u00e8ne dans la classification du risque de cancer de la prostate - RVH-Synergie.org","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/rvh-synergie.org\/actualites\/les-tests-de-classification-genomique-jouent-un-role-heterogene-dans-la-classification-du-risque-de-cancer-de-la-prostate\/","og_locale":"fr_FR","og_type":"article","og_title":"Les tests de classification g\u00e9nomique jouent un r\u00f4le h\u00e9t\u00e9rog\u00e8ne dans la classification du risque de cancer de la prostate - RVH-Synergie.org","og_description":"Pour les patients atteints d&rsquo;un cancer de la prostate localis\u00e9 (CaP), les classificateurs g\u00e9nomiques (GC)","og_url":"https:\/\/rvh-synergie.org\/actualites\/les-tests-de-classification-genomique-jouent-un-role-heterogene-dans-la-classification-du-risque-de-cancer-de-la-prostate\/","og_site_name":"RVH-Synergie","article_published_time":"2025-01-22T05:00:09+00:00","article_modified_time":"2025-01-22T05:00:10+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/01\/1737522009_Les-tests-de-classification-genomique-jouent-un-role-heterogene-dans.jpg","type":"image\/jpeg"}],"author":"Charles Martinez","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Charles Martinez","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/rvh-synergie.org\/actualites\/les-tests-de-classification-genomique-jouent-un-role-heterogene-dans-la-classification-du-risque-de-cancer-de-la-prostate\/#article","isPartOf":{"@id":"https:\/\/rvh-synergie.org\/actualites\/les-tests-de-classification-genomique-jouent-un-role-heterogene-dans-la-classification-du-risque-de-cancer-de-la-prostate\/"},"author":{"name":"Charles Martinez","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560"},"headline":"Les tests de classification g\u00e9nomique jouent un r\u00f4le h\u00e9t\u00e9rog\u00e8ne dans la classification du risque de cancer de la prostate","datePublished":"2025-01-22T05:00:09+00:00","dateModified":"2025-01-22T05:00:10+00:00","mainEntityOfPage":{"@id":"https:\/\/rvh-synergie.org\/actualites\/les-tests-de-classification-genomique-jouent-un-role-heterogene-dans-la-classification-du-risque-de-cancer-de-la-prostate\/"},"wordCount":386,"publisher":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#organization"},"image":{"@id":"https:\/\/rvh-synergie.org\/actualites\/les-tests-de-classification-genomique-jouent-un-role-heterogene-dans-la-classification-du-risque-de-cancer-de-la-prostate\/#primaryimage"},"thumbnailUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/01\/1737522009_Les-tests-de-classification-genomique-jouent-un-role-heterogene-dans.jpg","keywords":["cancer","classification","dans","g\u00e9nomique","h\u00e9t\u00e9rog\u00e8ne","jouent","Les","prostate","risque","r\u00f4le","tests"],"articleSection":["Les maladies"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/rvh-synergie.org\/actualites\/les-tests-de-classification-genomique-jouent-un-role-heterogene-dans-la-classification-du-risque-de-cancer-de-la-prostate\/","url":"https:\/\/rvh-synergie.org\/actualites\/les-tests-de-classification-genomique-jouent-un-role-heterogene-dans-la-classification-du-risque-de-cancer-de-la-prostate\/","name":"Les tests de classification g\u00e9nomique jouent un r\u00f4le h\u00e9t\u00e9rog\u00e8ne dans la classification du risque de cancer de la prostate - RVH-Synergie.org","isPartOf":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#website"},"primaryImageOfPage":{"@id":"https:\/\/rvh-synergie.org\/actualites\/les-tests-de-classification-genomique-jouent-un-role-heterogene-dans-la-classification-du-risque-de-cancer-de-la-prostate\/#primaryimage"},"image":{"@id":"https:\/\/rvh-synergie.org\/actualites\/les-tests-de-classification-genomique-jouent-un-role-heterogene-dans-la-classification-du-risque-de-cancer-de-la-prostate\/#primaryimage"},"thumbnailUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/01\/1737522009_Les-tests-de-classification-genomique-jouent-un-role-heterogene-dans.jpg","datePublished":"2025-01-22T05:00:09+00:00","dateModified":"2025-01-22T05:00:10+00:00","breadcrumb":{"@id":"https:\/\/rvh-synergie.org\/actualites\/les-tests-de-classification-genomique-jouent-un-role-heterogene-dans-la-classification-du-risque-de-cancer-de-la-prostate\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/rvh-synergie.org\/actualites\/les-tests-de-classification-genomique-jouent-un-role-heterogene-dans-la-classification-du-risque-de-cancer-de-la-prostate\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/rvh-synergie.org\/actualites\/les-tests-de-classification-genomique-jouent-un-role-heterogene-dans-la-classification-du-risque-de-cancer-de-la-prostate\/#primaryimage","url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/01\/1737522009_Les-tests-de-classification-genomique-jouent-un-role-heterogene-dans.jpg","contentUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/01\/1737522009_Les-tests-de-classification-genomique-jouent-un-role-heterogene-dans.jpg","width":1280,"height":853,"caption":"Les tests de classification g\u00e9nomique jouent un r\u00f4le h\u00e9t\u00e9rog\u00e8ne dans la classification du risque de cancer de la prostate"},{"@type":"BreadcrumbList","@id":"https:\/\/rvh-synergie.org\/actualites\/les-tests-de-classification-genomique-jouent-un-role-heterogene-dans-la-classification-du-risque-de-cancer-de-la-prostate\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/rvh-synergie.org\/actualites\/"},{"@type":"ListItem","position":2,"name":"Les tests de classification g\u00e9nomique jouent un r\u00f4le h\u00e9t\u00e9rog\u00e8ne dans la classification du risque de cancer de la prostate"}]},{"@type":"WebSite","@id":"https:\/\/rvh-synergie.org\/actualites\/#website","url":"https:\/\/rvh-synergie.org\/actualites\/","name":"RVH-Synergie.org","description":"RVH-Synergie, site ind\u00e9pendant d&#039;informations sur la prise en charge des addictions.","publisher":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/rvh-synergie.org\/actualites\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/rvh-synergie.org\/actualites\/#organization","name":"RVH-Synergie.org","url":"https:\/\/rvh-synergie.org\/actualites\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/","url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png","contentUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png","width":512,"height":512,"caption":"RVH-Synergie.org"},"image":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560","name":"Charles Martinez","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/image\/","url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg","contentUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg","caption":"Charles Martinez"},"description":"Bonjour, je m'appelle Charles Martinez, r\u00e9dacteur passionn\u00e9 pour le m\u00e9dia RVH-synergie.org, d\u00e9di\u00e9 aux addictions et aux maladies. Depuis plus de dix ans, j'explore et rapporte les histoires poignantes des individus confront\u00e9s \u00e0 ces d\u00e9fis, tout en sensibilisant le public aux traitements novateurs et aux progr\u00e8s scientifiques dans ce domaine. Mon engagement r\u00e9side dans l'espoir de cr\u00e9er une communaut\u00e9 inform\u00e9e et empathique, pr\u00eate \u00e0 soutenir ceux qui luttent contre ces \u00e9preuves.","sameAs":["https:\/\/rvh-synergie.org\/"]}]}},"_links":{"self":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/posts\/3710","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/comments?post=3710"}],"version-history":[{"count":0,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/posts\/3710\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/media\/3711"}],"wp:attachment":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/media?parent=3710"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/categories?post=3710"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/tags?post=3710"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}